公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | A KDM6A–KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction | Lin C.-L.; Hsu Y.-C.; Huang Y.-T.; Shih Y.-H.; Wang C.-J.; WEN-CHIH CHIANG ; Chang P.-J. | EMBO Molecular Medicine | 54 | 41 | |
2022 | Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan | Lo C.-C.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Chen C.-Y.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Chang T.S.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU ; Lee M.-H.; CHUN-JEN LIU ; Dai C.-Y.; Chuang W.-L.; Lin H.-C.; JIA-HORNG KAO ; Yu M.-L.; TACR investigators | Journal of the Formosan Medical Association | 3 | 0 | |
2013 | LMBD1 protein serves as a specific adaptor for insulin receptor internalization | Tseng L.T.-L.; Lin C.-L.; KAI-YUAN TZEN ; SHIN CHANG ; MING-FU CHANG | Journal of Biological Chemistry | 29 | 27 | |
2006 | Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area | WEI-LIANG SHIH ; MING-WHEI YU ; PEI-JER CHEN ; Shiou-Hwei Yeh ; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; CHUN-JEN LIU ; Lee S.-D.; Lin C.-L.; CHUHSING KATE HSIAO ; Yang S.-Y.; Chen C.-J. | Oncogene | 17 | 14 | |
2014 | Long-term risk of acute coronary syndrome in patients with cholangitis: A 13-year nationwide cohort study | Tsai M.-S.; Li Y.-F.; Lin C.-L.; Hsu Y.-C.; PO-HUANG LEE ; Sung F.-C.; Kao C.-H. | European Journal of Internal Medicine | 5 | 5 | |
2014 | Long-term risk of acute coronary syndrome in patients with inflammatory bowel disease: A 13-year nationwide cohort study in an asian population | Tsai M.-S.; Lin C.-L.; Chen H.-P.; PO-HUANG LEE ; Sung F.-C.; Kao C.-H. | Inflammatory Bowel Diseases | 31 | 24 | |
2015 | Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury | Tsai M.-S.; Chou S.-E.; HONG-SHIEE LAI ; Jeng L.-B.; Lin C.-L.; Kao C.-H. | Medicine (United States) | 6 | 8 | |
2015 | Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: A 13-year nationwide cohort study in an Asian population | Tsai M.-S.; Lin C.-L.; Chen H.-P.; PO-HUANG LEE ; Sung F.-C.; Kao C.-H. | American Journal of Surgery | 18 | 13 | |
2008 | Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men | Wu C.-F.; MING-WHEI YU ; Lin C.-L.; CHUN-JEN LIU ; WEI-LIANG SHIH ; KEH-SUNG TSAI ; Chen C.-J. | Carcinogenesis | 75 | 73 | |
2020 | Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma | Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; CHING-YU LIN ; Lin C.-L.; Hu J.-T.; Huang Y.-W.; CHUN-JEN LIU ; Wu W.-J.; Wu C.-F.; Sung F.-Y.; PEI-JER CHEN ; Liang H.-J.; Lin S.-M.; MING-WHEI YU | Molecular Carcinogenesis | 9 | 6 | |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 90 | 87 | |
2013 | Measurement precision of the disability for back pain scale-by applying Rasch analysis | Lu Y.-M.; Wu Y.-Y.; CHING-LIN HSIEH ; Lin C.-L.; Hwang S.-L.; Cheng K.-I.; Lue Y.-J. | Health and Quality of Life Outcomes | 20 | 15 | |
2019 | Methylene-blue-encapsulated liposomes as photodynamic therapy nano agents for breast cancer cells | Wu P.-T.; Lin C.-L.; Lin C.-W.; Chang N.-C.; Tsai W.-B.; Tsai W.-B. | Nanomaterials | 51 | 53 | |
2014 | MicroRNA-29a Promotion of nephrin acetylation ameliorates hyperglycemia-induced podocyte dysfunction | Lin C.-L.; Lee P.-H.; Hsu Y.-C.; Lei C.-C.; Ko J.-Y.; Chuang P.-C.; Huang Y.-T.; Wang S.-Y.; Wu S.-L.; Chen Y.-S.; WEN-CHIH CHIANG ; Reiser J.; Wang F.-S. | Journal of the American Society of Nephrology | 164 | 150 | |
1999 | Morphological alterations associated with the cytotoxic and cytostatic effects of citric acid on cultured human dental pulp cells | Chan C.-P.; JIIANG-HUEI JENG ; Hsieh C.-C.; Lin C.-L.; Lei D.; Chang M.-C. | Journal of Endodontics | 18 | 20 | |
2021 | Nanoscale redox mapping at the MoS2-liquid interface | Du H.-Y.; Huang Y.-F.; Wong D.; Tseng M.-F.; Lee Y.-H.; Wang C.-H.; Lin C.-L.; Hoffmann G.; Chen K.-H.; Chen L.-C.; LI-CHYONG CHEN | Nature Communications | 13 | 11 | |
2021 | Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan | Huang C.-F.; Kuo H.-T.; Chang T.-S.; Lo C.-C.; Hung C.-H.; Huang C.-W.; Chong L.-W.; Cheng P.-N.; Yeh M.-L.; Peng C.-Y.; Cheng C.-Y.; Huang J.-F.; Bair M.-J.; Lin C.-L.; Yang C.-C.; Wang S.-J.; Hsieh T.-Y.; Lee T.-H.; Lee P.-L.; Wu W.-C.; Lin C.-L.; Su W.-W.; Yang S.-S.; Wang C.-C.; Hu J.-T.; Mo L.-R.; Chen C.-T.; Huang Y.-H.; Chang C.-C.; Huang C.-S.; Chen G.-Y.; Kao C.-N.; Tai C.-M.; CHUN-JEN LIU ; Lee M.-H.; Tsai P.-C.; Dai C.-Y.; JIA-HORNG KAO ; Lin H.-C.; Chuang W.-L.; Chen C.-Y.; Tseng K.-C.; Yu M.-L. | Scientific Reports | 9 | 5 | |
2017 | Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants | Lin C.-L.; JIA-HORNG KAO | Best Practice and Research: Clinical Gastroenterology | 133 | 115 | |
2019 | A new avenue for treating neuronal diseases: Ceftriaxone, an old antibiotic demonstrating behavioral neuronal effects | CHUN-HWEI TAI ; Bellesi M.; Chen A.-C.; Lin C.-L.; Li H.-H.; Lin P.-J.; Liao W.-C.; Hung C.-S.; Schwarting R.K.; Ho Y.-J. | Behavioural Brain Research | 23 | 23 | |
2016 | New perspectives of biomarkers for the management of chronic hepatitis B | Lin C.-L.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 48 | 0 | |